Compare Grifols SA with Similar Stocks
Dashboard
1
High Debt company with Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate 4.97% of over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
With ROE of 9.13%, it has a Very Expensive valuation with a 1.09 Price to Book Value
3
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-71.48%
0%
-71.48%
6 Months
-75.72%
0%
-75.72%
1 Year
-71.68%
0%
-71.68%
2 Years
-69.9%
0%
-69.9%
3 Years
-71.88%
0%
-71.88%
4 Years
-59.48%
0%
-59.48%
5 Years
-81.3%
0%
-81.3%
Grifols SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
10.24%
EBIT Growth (5y)
4.97%
EBIT to Interest (avg)
3.05
Debt to EBITDA (avg)
4.51
Net Debt to Equity (avg)
1.65
Sales to Capital Employed (avg)
0.45
Tax Ratio
47.48%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
9.46%
ROE (avg)
10.00%
Valuation key factors
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
1.08
EV to EBIT
10.14
EV to EBITDA
7.50
EV to Capital Employed
1.04
EV to Sales
1.68
PEG Ratio
0.10
Dividend Yield
2.24%
ROCE (Latest)
10.23%
ROE (Latest)
9.13%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
1,981.70
1,975.80
0.30%
Operating Profit (PBDIT) excl Other Income
403.20
492.10
-18.07%
Interest
160.00
161.30
-0.81%
Exceptional Items
0.00
0.00
Consolidate Net Profit
125.80
83.80
50.12%
Operating Profit Margin (Excl OI)
138.70%
193.30%
-5.46%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is 0.30% vs 11.66% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is 50.12% vs 7.02% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
7,524.00
7,212.40
4.32%
Operating Profit (PBDIT) excl Other Income
1,686.00
1,562.30
7.92%
Interest
625.00
714.80
-12.56%
Exceptional Items
30.00
10.80
177.78%
Consolidate Net Profit
500.00
212.80
134.96%
Operating Profit Margin (Excl OI)
164.30%
155.90%
0.84%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 4.32% vs 9.41% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 134.96% vs 17.76% in Dec 2024
About Grifols SA 
Grifols SA
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






